FI Anonymous

As you can see in my portfolio , Abbvie Inc (ABBV) is one of my largest holdings, and one of my most significant dividend producers. I've made multiple purchases of the stock throughout the past few years, and as recently as this past month. But how do I like the stock at its current price? Let's take a look at the metrics and break them down.  The Breakdown With a yield over 5%, Abbvie impresses. And even more impressive, this yield is backed up by 47 consecutive years of dividend increases (adjusted for spin-off from Abbot Labs), and the company has grown their dividend at an average rate of nearly 20% over the past five years.  The trailing P/E of 16x is lower than the typical level ABBV trades, though the forward ratio is a bit higher than has been typical over the past couple years. However, the P/E is not at a level I'd consider concerning, and forward analyst earnings estimates likely take into account any additional costs of the company's upcoming merger with dr

As I had mentioned in the retirement planning resources section of my blog, I've been getting questions from friends and family lately that brought me to a realization. The general public does not understand the basics of Individual Retirement Accounts, or IRAs, one of the most common retirement planning vehicles available in the US. Coming from an education in a business and finance related field, I took for granted the fact that I had a good understanding of the rules, tax advantages, and strategies of IRA accounts. After realizing this, I felt that it would be best to attempt to share my knowledge in an easy to read format - for a quick 'cheat sheet' of everything you need to know to get started thinking about IRA accounts, see here .  To add a bit more commentary and color to these quick 'cheat sheets', I decided it was best to get all my thoughts in an article. So without further adieu, let's take a dive into the details of IRAs. The Two Main Types - Tradi